Introducing Yseop Copilot, the world’s most trusted digital colleague for automating scientific writing. Reimagine your scientific writing journey.
- Tweets5.4K
- Following1.6K
- Followers1.6K
- Likes506
ALT The FDA’s adoption of GenAI to review regulatory submissions marks a turning point for the industry. In Clinical Trials Arena, Pierre-Louis Durel, VP Corporate Development at Yseop, discusses how this shift raises the bar for dossier quality and how sponsors can stay ahead. From structured submissions to the role of human oversight, the interview outlines what pharma teams need to know now. The European Medicines Agency is not far behind. Read the article via Yahoo Finance
ALT The FDA’s adoption of GenAI to review regulatory submissions marks a turning point for the industry. In Clinical Trials Arena, Pierre-Louis Durel, VP Corporate Development at Yseop, discusses how this shift raises the bar for dossier quality and how sponsors can stay ahead. From structured submissions to the role of human oversight, the interview outlines what pharma teams need to know now. The European Medicines Agency is not far behind. Read the article via Yahoo Finance
ALT Yseop is shaping the future of regulatory submissions with the One-Click Dossier, our bold move toward fully automated, compliant document generation. As submission timelines tighten and document complexity increases, the need for intelligent, scalable automation is clear. One-Click Dossier brings together: ✔️ Real-time data integration ✔️ Generative AI-powered content creation ✔️ Flexible, modular templates This approach redefines how regulatory documents are created, improving both speed and consistency while maintaining the highest quality standards. We're delivering what's next in regulatory writing. Read the full announcement
ALT Yseop is shaping the future of regulatory submissions with the One-Click Dossier, our bold move toward fully automated, compliant document generation. As submission timelines tighten and document complexity increases, the need for intelligent, scalable automation is clear. One-Click Dossier brings together: ✔️ Real-time data integration ✔️ Generative AI-powered content creation ✔️ Flexible, modular templates This approach redefines how regulatory documents are created, improving both speed and consistency while maintaining the highest quality standards. We're delivering what's next in regulatory writing. Read the full announcement
ALT Yseop is shaping the future of regulatory submissions with the One-Click Dossier, our bold move toward fully automated, compliant document generation. As submission timelines tighten and document complexity increases, the need for intelligent, scalable automation is clear. One-Click Dossier brings together: ✔️ Real-time data integration ✔️ Generative AI-powered content creation ✔️ Flexible, modular templates This approach redefines how regulatory documents are created, improving both speed and consistency while maintaining the highest quality standards. We're delivering what's next in regulatory writing. Read the full announcement
ALT Today, Yseop is unveiling its roadmap for the One-Click Dossier. This is a bold step toward fully automated regulatory submissions. As regulatory timelines tighten and complexity increases, the need for scalable, compliant automation is more urgent than ever. One-Click Dossier brings together live data integration, AI-powered content generation, and adaptive templates to transform how clinical documents are created. We’re sharing more at the DIA Annual Meeting in Washington, DC this week: 📍 Visit us at Booth 609 through Wednesday 🎤 Join our session tomorrow at 11:45 AM in Innovation Theater 2 Read the full announcement
ALT Today, Yseop is unveiling its roadmap for the One-Click Dossier. This is a bold step toward fully automated regulatory submissions. As regulatory timelines tighten and complexity increases, the need for scalable, compliant automation is more urgent than ever. One-Click Dossier brings together live data integration, AI-powered content generation, and adaptive templates to transform how clinical documents are created. We’re sharing more at the DIA Annual Meeting in Washington, DC this week: 📍 Visit us at Booth 609 through Wednesday 🎤 Join our session tomorrow at 11:45 AM in Innovation Theater 2 Read the full announcement
ALT Join us at #DIA2025 in Washington, DC, next week from June 16 to 18. Visit the Yseop team at Booth 609 to see how Yseop Copilot is redefining regulatory writing with Generative AI. Learn how our One Click Dossier capability supports faster submissions, stronger compliance, and scalable efficiency across regulatory teams. Innovation Theater Session Tuesday, June 17 11:45 AM to 12:15 PM Innovation Theater 2 Presented by @ Jenni Pickett, Director of Medical Writing Customer Success at Yseop Details
ALT Join us at #DIA2025 in Washington, DC, next week from June 16 to 18. Visit the Yseop team at Booth 609 to see how Yseop Copilot is redefining regulatory writing with Generative AI. Learn how our One Click Dossier capability supports faster submissions, stronger compliance, and scalable efficiency across regulatory teams. Innovation Theater Session Tuesday, June 17 11:45 AM to 12:15 PM Innovation Theater 2 Presented by @ Jenni Pickett, Director of Medical Writing Customer Success at Yseop Details
ALT AI in life sciences shouldn’t be a black box. At Yseop, we believe automation in regulatory and medical writing must be structured, traceable, and compliant by design, not retrofitted. That’s why Copilot isn’t built for open-ended chat. It’s designed to support your workflow, reduce risk, and scale content generation with full auditability. Learn how enterprise teams are applying automation to regulatory writing with confidence
ALT AI in life sciences shouldn’t be a black box. At Yseop, we believe automation in regulatory and medical writing must be structured, traceable, and compliant by design, not retrofitted. That’s why Copilot isn’t built for open-ended chat. It’s designed to support your workflow, reduce risk, and scale content generation with full auditability. Learn how enterprise teams are applying automation to regulatory writing with confidence
ALT It’s the final day of the Veeva R&D and Quality Summit Europe! If you haven’t yet, come by Booth S7 to discover how Yseop is transforming regulatory and medical writing with the next phase of our Veeva Vault integration. We’re building smarter content access and faster drafting designed with and for medical writers. Let’s chat about how it could work for your team
